Cerenome is trading 10.70% up at $2.07 after announcing a September 30, 2026, business update call focused on CNSide commercial progress. - Management plans to discuss third-party billing, market access, commercial-team expansion, and broader diagnostic testing. - Broader healthcare-sector strength offers additional support. - Recent volatility included closes ranging from $1.87 to $2.03 during September 21–24.